Senti Biosciences Holdings, Inc. (SNTI)
1.09
0.00 (0.00%)
USD |
NASDAQ |
Jun 29, 09:54
Senti Biosciences Holdings Free Cash Flow : -37.07M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | -37.07M |
| December 31, 2025 | -43.64M |
| September 30, 2025 | -50.28M |
| June 30, 2025 | -48.70M |
| March 31, 2025 | -43.78M |
| December 31, 2024 | -41.42M |
| September 30, 2024 | -34.95M |
| June 30, 2024 | -44.32M |
| March 31, 2024 | -53.32M |
| Date | Value |
|---|---|
| December 31, 2023 | -64.43M |
| September 30, 2023 | -74.93M |
| June 30, 2023 | -82.03M |
| March 31, 2023 | -81.64M |
| December 31, 2022 | -76.27M |
| September 30, 2022 | -74.69M |
| June 30, 2022 | -60.09M |
| March 31, 2022 | -57.62M |
| December 31, 2021 | -40.18M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| NovelStem International Corp. | -0.2627M |
| Brainstorm Cell Therapeutics, Inc. | -6.664M |
| Summit Therapeutics, Inc. | -387.48M |
| Kezar Life Sciences, Inc. | -42.03M |
| Protara Therapeutics, Inc. | -63.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.481M |
| Cash from Investing (Quarterly) | 0.114M |
| Cash from Financing (Quarterly) | -0.118M |
| Free Cash Flow Per Share (Quarterly) | -0.2415 |
| Free Cash Flow to Equity (Quarterly) | 2.269M |
| Free Cash Flow to Firm (Quarterly) | -7.481M |
| Free Cash Flow Yield | -122.9% |